Diabetes Clinical Trial
Official title:
Feasibility Study to Assess the Safety and Functionality of the GluSense-LTone 2e3 Continuous Glucose Monitor in Diabetic Patients
Verified date | December 2010 |
Source | GluSense Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | Slovenia: Ministry of Health |
Study type | Interventional |
Currently marketed CGM sensors have an approved functional lifetime of up to 1 week.
Pre-clinical studies have demonstrated that GluSense-LTone 2e3 sensors may be used to
accurately monitor glucose levels for 30 days. The purpose of this study is to assess the
safety and functionality of the device in human patients for consecutive 15 days.
GluSense-LTone 2e3 as long term CGM, will require less sensor replacements and calibration,
meaning less patient interventions, and is therefore will be much more user friendly.
Moreover, GluSense-LTone 2e3 shows potentially increased accuracy, especially in the
critically important hypoglycemic range, meaning that better management of patient's
condition may be attained.
Status | Completed |
Enrollment | 12 |
Est. completion date | February 2011 |
Est. primary completion date | January 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: Patients must meet all of the following inclusion criteria to be eligible for participation in this study: - Male or female patients between 18 and 50 years of age - Patients with type 1 diabetes mellitus. - The ability to read, understand and sign an informed consent form. Written consent must be obtained prior to initiation of study procedures Exclusion Criteria: Patients who meet any of the following exclusion criteria are not to be enrolled in this study: - Clinical significant illness that can compromise patient's health during study such as: - Significant current heart disease - Significant Liver or kidney disease - HIV infection - Hepatitis B or Hepatitis C infection - Malignancy - Major allergic skin disease including plaster allergies - Significant allergic disorders - Current or recent significant skin conditions (e.g. eczema, psoriasis,). - Presence of skin markings/ abnormalities around implantation site that will interfere with the skin assessment e.g. tattoos, piercings, birthmark, sunburn - Current alcohol or substance use judged by the IP to potentially interfere with patient study compliance. - Routine administration of Steroid based medications. - Patients currently taking part in any other clinical trial using an investigational product within the last 3 months |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
Slovenia | University medical Center Ljubljana | Ljubljana |
Lead Sponsor | Collaborator |
---|---|
GluSense Ltd |
Slovenia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluate capability to follow glucose concentration changes over 15 consecutive days | 3 weeks | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |